Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-005053
Filing Date
2022-06-10
Accepted
2022-06-10 18:34:07
Documents
1
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 19093
  Complete submission text file 0001562180-22-005053.txt   20397
Mailing Address 3200 WALNUT ST BOULDER CO 80301
Business Address
MOORE JOHN R (Reporting) CIK: 0001191702 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40236 | Film No.: 221010260

Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Issuer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations